Market revenue in 2023 | USD 14,164.4 million |
Market revenue in 2030 | USD 17,073.8 million |
Growth rate | 2.7% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Human & Tumor Genetics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 47.92% in 2023. Horizon Databook has segmented the Germany clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
Germany held the largest share in the Europe clinical laboratory services market owing to a large number of laboratories and easy availability of innovative technology. The country’s reimbursement scenario is also lenient owing to higher prices set by manufacturers, as Germany maintains maximum VAT on medical devices.
However, the reimbursement limits compel manufacturers to restrict their use of technology to meet returns on investments. Recently, this market has witnessed consolidation among private laboratories, which purchase or work on behalf of hospitals.
This has positively influenced the market through the availability of group purchases. The country has conducted a significant number of COVID-19 diagnostic tests with a combined effort from government testing labs and private laboratories.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany clinical laboratory service market , including forecasts for subscribers. This country databook contains high-level insights into Germany clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account